WXXWY News and Press, Wuxi Biologics Cayman Inc ADR From 06/30/25

WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL PR Newswire The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to enable concentrat...

WuXi Biologics Kicks off Construction of Microbial Manufacturing Site for Commercial Production in Chengdu PR Newswire The microbial manufacturing site in Chengdu will be equipped with a 15,000L fermenter, enabling the production of 80 to 110 drug substance (DS) batches an...

2025-05-22 08:05:00 ET Summary Global equity markets diverged in Q1 2025, with U.S. equities underperforming due to aggressive tariffs and geopolitical tensions, while Europe and China showed resilience. Our investment strategy emphasizes long-term secular growth trends, strong co...

2025-05-18 04:04:32 ET Summary I have lowered my rating for WuXi Biologics from a Buy to a Hold, taking into consideration its financial prospects and risk factors. In the long run, the onshoring of drug manufacturing in the U.S. might limit WuXi's growth potential for the long ru...

WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA PR Newswire Enabled by WuXi Biologics' industry-leading integrated technology platform, velaglucerase-be...

Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report PR Newswire Contributing to United Nations Sustainable Development Goals Enhancing transparency and effectiveness for corporate governance Empowering employees and delivering posi...

2025-04-28 08:09:00 ET Summary Baron Emerging Markets Fund increased in the first quarter of 2025, outperforming its benchmark, the MSCI EM Index. Emerging markets equities outperformed as the uncertainty generated by Trump’s tariff war spurred a broad-based rotation out of...

WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year PR Newswire Firm commitment to tackling climate change in support of United Nations Sustainable Development Goals Earth Day 2025 - Our Power, Our Planet, Contribute to a sustainable ...

WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site PR Newswire -          The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,000L single-use bior...

WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards PR Newswire SHANGHAI , April 14, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that i...